A total of 89.8 % of the Cuban population has already completed the vaccination program against COVID-19, with the immunogens developed in the country, Soberana 02, Soberana Plus and Abdala.
The Cuban Neuroscience Center (Cneuro) is currently working on the NeuroGer system, aimed at treating senior citizens with cognitive disorders.
Experiences on the control and management of Covid-19, cancer immunotherapy and agricultural biotechnology on Wednesday focus the debates of the BioHabana 2022 International Congress, scheduled until Friday.
The health system in the province of Holguín maintains the control measures of COVID-19 for the protection of vulnerable sectors, even when the eastern territory reduces the incidence rates of the disease, declared a pandemic by the World Health Organization.
Cuba maintains an exchange with the WHO on the process of international recognition of its anti-Covid-19 vaccines with the Abdala dossier ready and that of the Sovereign line immunizers in preparation, an authority said today.